Literature DB >> 19276087

Phosphorylation of collapsin response mediator protein 2 on Tyr-479 regulates CXCL12-induced T lymphocyte migration.

Michel Varrin-Doyer1, Peggy Vincent, Sylvie Cavagna, Nathalie Auvergnon, Nelly Noraz, Véronique Rogemond, Jérôme Honnorat, Mahnaz Moradi-Améli, Pascale Giraudon.   

Abstract

In the central nervous system, collapsin response mediator protein 2 (CRMP2) is a transducer protein that supports the semaphorin-induced guidance of axons toward their cognate target. However, we previously showed that CRMP2 is also expressed in immune cells and plays a crucial role in T lymphocyte migration. Here we further investigated the molecular mechanisms underlying CRMP2 function in chemokine-directed T-cell motility. Examining Jurkat T-cells treated with the chemokine CXCL12, we found that 1) CXCL12 induces a dynamic re-localization of CRMP2 to uropod, the flexible structure of migrating lymphocyte, and increases its binding to the cytoskeletal protein vimentin; 2) CXCL12 decreases phosphorylation of the glycogen synthase kinase-3beta-targeted residues CRMP2-Thr-509/514; and 3) tyrosine Tyr-479 is a new phosphorylation CRMP2 residue and a target for the Src-family kinase Yes. Moreover, phospho-Tyr-479 increased under CXCL12 signaling while phospho-Thr-509/514 decreased. The functional importance of this tyrosine phosphorylation was demonstrated by Y479F mutation that strongly reduced CXCL12-mediated T-cell polarization and motility as tested in a transmigration model and on neural tissue. We propose that differential phosphorylation by glycogen synthase kinase-3beta and Yes modulates the contribution of CRMP2 to cytoskeletal reorganization during chemokine-directed T-cell migration. In addition to providing a novel mechanism for T lymphocyte motility, our findings reveal CRMP2 as a transducer of chemokine signaling.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19276087      PMCID: PMC2676058          DOI: 10.1074/jbc.M807664200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

1.  TUC-4b, a novel TUC family variant, regulates neurite outgrowth and associates with vesicles in the growth cone.

Authors:  Christopher C Quinn; Esteban Chen; Tashi G Kinjo; Gail Kelly; Alexander W Bell; Robert C Elliott; Peter S McPherson; Susan Hockfield
Journal:  J Neurosci       Date:  2003-04-01       Impact factor: 6.167

2.  Rigidity of circulating lymphocytes is primarily conferred by vimentin intermediate filaments.

Authors:  M J Brown; J A Hallam; E Colucci-Guyon; S Shaw
Journal:  J Immunol       Date:  2001-06-01       Impact factor: 5.422

3.  Measurement of the levels of polymerized actin (F-actin) in chemokine-stimulated lymphocytes and GFP-coupled cDNA transfected lymphoid cells by flow cytometry.

Authors:  Miguel Vicente-Manzanares; Mariano Vitón; Francisco Sánchez-Madrid
Journal:  Methods Mol Biol       Date:  2004

Review 4.  Homing and cellular traffic in lymph nodes.

Authors:  Ulrich H von Andrian; Thorsten R Mempel
Journal:  Nat Rev Immunol       Date:  2003-11       Impact factor: 53.106

5.  Evidence for a role of Collapsin response mediator protein-2 in signaling pathways that regulate the proliferation of non-neuronal cells.

Authors:  Candice Ginn T Tahimic; Nozomi Tomimatsu; Ryuichi Nishigaki; Akiko Fukuhara; Tosifusa Toda; Kozo Kaibuchi; Goshi Shiota; Mitsuo Oshimura; Akihiro Kurimasa
Journal:  Biochem Biophys Res Commun       Date:  2006-01-05       Impact factor: 3.575

6.  A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors.

Authors:  Joshua B Rubin; Andrew L Kung; Robyn S Klein; Jennifer A Chan; YanPing Sun; Karl Schmidt; Mark W Kieran; Andrew D Luster; Rosalind A Segal
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-31       Impact factor: 11.205

7.  CRMP-2 binds to tubulin heterodimers to promote microtubule assembly.

Authors:  Yuko Fukata; Tomohiko J Itoh; Toshihide Kimura; Céline Ménager; Takashi Nishimura; Takashi Shiromizu; Hiroyasu Watanabe; Naoyuki Inagaki; Akihiro Iwamatsu; Hirokazu Hotani; Kozo Kaibuchi
Journal:  Nat Cell Biol       Date:  2002-08       Impact factor: 28.824

8.  CRMP-2 regulates polarized Numb-mediated endocytosis for axon growth.

Authors:  Takashi Nishimura; Yuko Fukata; Katsuhiro Kato; Tomoya Yamaguchi; Yoshiharu Matsuura; Hiroyuki Kamiguchi; Kozo Kaibuchi
Journal:  Nat Cell Biol       Date:  2003-08-24       Impact factor: 28.824

9.  The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints.

Authors:  Robert Fredriksson; Malin C Lagerström; Lars-Gustav Lundin; Helgi B Schiöth
Journal:  Mol Pharmacol       Date:  2003-06       Impact factor: 4.436

Review 10.  Collapsin response mediator proteins (CRMPs): involvement in nervous system development and adult neurodegenerative disorders.

Authors:  Emmanuelle Charrier; Sophie Reibel; Véronique Rogemond; Michèle Aguera; Nicole Thomasset; Jérôme Honnorat
Journal:  Mol Neurobiol       Date:  2003-08       Impact factor: 5.682

View more
  24 in total

Review 1.  Collapsin response mediator proteins regulate neuronal development and plasticity by switching their phosphorylation status.

Authors:  Naoya Yamashita; Yoshio Goshima
Journal:  Mol Neurobiol       Date:  2012-02-18       Impact factor: 5.590

2.  Fyn promotes phosphorylation of collapsin response mediator protein 1 at tyrosine 504, a novel, isoform-specific regulatory site.

Authors:  Gwen R Buel; John Rush; Bryan A Ballif
Journal:  J Cell Biochem       Date:  2010-09-01       Impact factor: 4.429

3.  Phosphorylated CRMP2 Regulates Spinal Nociceptive Neurotransmission.

Authors:  Jie Yu; Aubin Moutal; Angie Dorame; Shreya S Bellampalli; Aude Chefdeville; Iori Kanazawa; Nancy Y N Pham; Ki Duk Park; Jill M Weimer; Rajesh Khanna
Journal:  Mol Neurobiol       Date:  2018-12-18       Impact factor: 5.590

4.  Collapsin response mediator protein-2 phosphorylation promotes the reversible retraction of oligodendrocyte processes in response to non-lethal oxidative stress.

Authors:  Agata Fernández-Gamba; María Celeste Leal; Chera L Maarouf; Christiane Richter-Landsberg; Terence Wu; Laura Morelli; Alex E Roher; Eduardo M Castaño
Journal:  J Neurochem       Date:  2012-04-27       Impact factor: 5.372

5.  Vertebrate paralogous CRMPs in nervous system: evolutionary, structural, and functional interplay.

Authors:  Yanyan Tang; Ziming Ye; Yunfei Wei; Cuiting Lin; Yongbo Wang; Chao Qin
Journal:  J Mol Neurosci       Date:  2014-06-05       Impact factor: 3.444

6.  Dynamic CRMP2 Regulation of CaV2.2 in the Prefrontal Cortex Contributes to the Reinstatement of Cocaine Seeking.

Authors:  William C Buchta; Aubin Moutal; Bethany Hines; Constanza Garcia-Keller; Alexander C W Smith; Peter Kalivas; Rajesh Khanna; Arthur C Riegel
Journal:  Mol Neurobiol       Date:  2019-07-29       Impact factor: 5.590

7.  Tax and Semaphorin 4D Released from Lymphocytes Infected with Human Lymphotropic Virus Type 1 and Their Effect on Neurite Growth.

Authors:  Sebastián Quintremil; Carolina Alberti; Matías Rivera; Fernando Medina; Javier Puente; Luis Cartier; Eugenio Ramírez; Yuetsu Tanaka; M Antonieta Valenzuela
Journal:  AIDS Res Hum Retroviruses       Date:  2015-09-21       Impact factor: 2.205

8.  Hierarchical CRMP2 posttranslational modifications control NaV1.7 function.

Authors:  Erik T Dustrude; Aubin Moutal; Xiaofang Yang; Yuying Wang; May Khanna; Rajesh Khanna
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-08       Impact factor: 11.205

Review 9.  Innate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3).

Authors:  Eléonore Beurel; Suzanne M Michalek; Richard S Jope
Journal:  Trends Immunol       Date:  2009-10-14       Impact factor: 16.687

10.  Insight into the role of CRMP2 (collapsin response mediator protein 2) in T lymphocyte migration: the particular context of virus infection.

Authors:  Pascale Giraudon; Adeline Nicolle; Sylvie Cavagna; Claire Benetollo; Romain Marignier; Michel Varrin-Doyer
Journal:  Cell Adh Migr       Date:  2012-10-17       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.